Literature DB >> 19139448

Lack of impact of direct-to-consumer advertising on the physician-patient encounter in primary care: a SNOCAP report.

Bennett Parnes1, Peter C Smith, Christine Gilroy, Javan Quintela, Caroline B Emsermann, L Miriam Dickinson, John M Westfall.   

Abstract

PURPOSE: Direct-to-consumer advertising (DTCA) has increased tremendously during the past decade. Recent changes in the DTCA environment may have affected its impact on clinical encounters. Our objective was to determine the rate of patient medication inquiries and their influence on clinical encounters in primary care.
METHODS: Our methods consisted of a cross-sectional survey in the State Networks of Colorado Ambulatory Practices and Partners, a collaboration of 3 practice-based research networks. Clinicians completed a short patient encounter form after consecutive patient encounter for one-half or 1 full day. The main outcomes were the rate of inquiries, independent predictors of inquiries, and overall impact on clinical encounters.
RESULTS: One hundred sixty-eight clinicians in 22 practices completed forms after 1,647 patient encounters. In 58 encounters (3.5%), the patient inquired about a specific new prescription medication. Community health center patients made fewer inquiries than private practice patients (1.7% vs 7.2%, P<.001). Predictors of inquiries included taking 3 or more chronic medications and the clinician being female. Most clinicians reported the requested medication was not their first choice for treatment (62%), but it was prescribed in 53% of the cases. Physicians interpreted the overall impact on the visit as positive in 24% of visits, neutral in 66%, and negative in 10%.
CONCLUSIONS: Patient requests for prescription medication were uncommon overall, and even more so among patients in lower income groups. These requests were rarely perceived by clinicians as having a negative impact on the encounter. Future mixed methods studies should explore specific socioeconomic groups and reasons for clinicians' willingness to prescribe these medications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139448      PMCID: PMC2625841          DOI: 10.1370/afm.870

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN: 1544-1709            Impact factor:   5.166


  12 in total

1.  Direct-to-consumer ads can influence behavior. Advertising increases consumer knowledge and prescription drug requests.

Authors:  M Peyrot; N M Alperstein; D Van Doren; L G Poli
Journal:  Mark Health Serv       Date:  1998

2.  Direct-to-consumer advertising: is it too late to manage the risks?

Authors:  David A Kessler; Douglas A Levy
Journal:  Ann Fam Med       Date:  2007 Jan-Feb       Impact factor: 5.166

3.  How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior.

Authors:  W David Bradford; Andrew N Kleit; Paul J Nietert; Terrence Steyer; Thomas McIlwain; Steven Ornstein
Journal:  Health Aff (Millwood)       Date:  2006 Sep-Oct       Impact factor: 6.301

4.  Time to ban direct-to-consumer prescription drug marketing.

Authors:  Kurt C Stange
Journal:  Ann Fam Med       Date:  2007 Mar-Apr       Impact factor: 5.166

5.  Direct-to-consumer marketing of prescription drugs: creating consumer demand.

Authors:  M F Hollon
Journal:  JAMA       Date:  1999-01-27       Impact factor: 56.272

6.  Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing.

Authors:  Michele M Spence; Stephanie S Teleki; T Craig Cheetham; Stuart O Schweitzer; Mirta Millares
Journal:  Med Care Res Rev       Date:  2005-10       Impact factor: 3.929

7.  Missing clinical information during primary care visits.

Authors:  Peter C Smith; Rodrigo Araya-Guerra; Caroline Bublitz; Bennett Parnes; L Miriam Dickinson; Rebecca Van Vorst; John M Westfall; Wilson D Pace
Journal:  JAMA       Date:  2005-02-02       Impact factor: 56.272

8.  Provider deferred decisions on hemoglobin A1c results: a report from the Colorado Research Network (CaReNet) and the High Plains Research Network (HPRN).

Authors:  Bennett Parnes; Linda Niebauer; Sherry Holcomb; Miriam Dickinson; Jack Westfall; Becky Vanvorst; Wilson Pace
Journal:  J Am Board Fam Med       Date:  2006 Jan-Feb       Impact factor: 2.657

9.  Clinical decisions regarding HbA1c results in primary care: a report from CaReNet and HPRN.

Authors:  Bennett L Parnes; Deborah S Main; L Miriam Dickinson; Linda Niebauer; Sherry Holcomb; John M Westfall; Wilson D Pace
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

10.  How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.

Authors:  Barbara Mintzes; Morris L Barer; Richard L Kravitz; Ken Bassett; Joel Lexchin; Arminée Kazanjian; Robert G Evans; Richard Pan; Stephen A Marion
Journal:  CMAJ       Date:  2003-09-02       Impact factor: 8.262

View more
  9 in total

1.  Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic?

Authors:  C Lee Ventola
Journal:  P T       Date:  2011-10

2.  The complexity of and opportunity for screening in primary care.

Authors:  Kurt C Stange
Journal:  Ann Fam Med       Date:  2009 Jan-Feb       Impact factor: 5.166

Review 3.  Effects of Direct-To-Consumer Advertising on Patient Prescription Requests and Physician Prescribing: A Systematic Review of Psychiatry-Relevant Studies.

Authors:  Sara J Becker; Miriam M Midoun
Journal:  J Clin Psychiatry       Date:  2016-10       Impact factor: 4.384

4.  Effects of patient medication requests on physician prescribing behavior: results of a factorial experiment.

Authors:  John B McKinlay; Felicia Trachtenberg; Lisa D Marceau; Jeffrey N Katz; Michael A Fischer
Journal:  Med Care       Date:  2014-04       Impact factor: 2.983

5.  Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review.

Authors:  Jessica T DeFrank; Nancy D Berkman; Leila Kahwati; Katherine Cullen; Kathryn J Aikin; Helen W Sullivan
Journal:  Health Commun       Date:  2019-04-11

6.  Card studies for observational research in practice.

Authors:  John M Westfall; Linda Zittleman; Elizabeth W Staton; Bennett Parnes; Peter C Smith; Linda J Niebauer; Douglas H Fernald; Javan Quintela; Rebecca F Van Vorst; L Miriam Dickinson; Wilson D Pace
Journal:  Ann Fam Med       Date:  2011 Jan-Feb       Impact factor: 5.166

7.  Direct-to-consumer and physician promotion of tegaserod correlated with physician visits, diagnoses, and prescriptions.

Authors:  Spencer D Dorn; Joel F Farley; Richard A Hansen; Nilay D Shah; Robert S Sandler
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

8.  Direct-to-consumer television advertising exposure, diagnosis with high cholesterol, and statin use.

Authors:  Jeff Niederdeppe; Sahara Byrne; Rosemary J Avery; Jonathan Cantor
Journal:  J Gen Intern Med       Date:  2013-03-06       Impact factor: 5.128

9.  A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising.

Authors:  Dominick L Frosch; David Grande; Derjung M Tarn; Richard L Kravitz
Journal:  Am J Public Health       Date:  2010-01       Impact factor: 9.308

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.